cjc-1295 and ipamorelin CJC-1295/Ipamorelin Injections CJC-1295/Ipamorelin Guide: Benefits, Dosage &

A 2004 study in The Journal of Clinical Endocrinology & Metabolism tested Ipamorelin at doses from 0.5 mcg/kg to 1.5 mcg/kg in healthy adults and found dose-dependent GH release with peak levels at 6090 minutes post-injection

Tesamorelin is FDAapproved for HIVassociated lipodystrophy, but this combination and its use for general body recomposition are offlabel and nonFDA-approved

IGF-1 LR3 (1 mg) $250.00 IGF-1 LR3 (Insulin-like Growth Factor-1) is a peptide that promotes muscle growth and repair by enhancing protein synthesis

Always use sun protection during the day, as UV exposure can counteract the brightening effect and may cause more dark spots

European Journal of Endocrinology , 139(5), 552-561